Cargando…
Recent Progress in the Development and Clinical Application of New Drugs for Transthyretin Cardiac Amyloidosis
Transthyretincardiac amyloidosis is a rare disease that has gained significant attention in recent years because of misfolding of transthyretin fibrils produced by the liver, leading to their deposition in the myocardium. The disease has an insidious onset, nonspecific clinical manifestations, and h...
Autores principales: | Zhou, Juan, Li, Yanfang, Geng, Jing, Zhou, Hong, Liu, Lian, Peng, Xiaochun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Cardiovascular Pharmacology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691666/ https://www.ncbi.nlm.nih.gov/pubmed/37678276 http://dx.doi.org/10.1097/FJC.0000000000001478 |
Ejemplares similares
-
GROUND GLASS LUNG OPACITIES AMIDST COVID-19 PANDEMIC: A CASE OF EARLY MANIFESTATION OF AMIODARONE-INDUCED PULMONARY TOXICITY
por: GOEL, M., et al.
Publicado: (2022) -
COMPARATIVE EFFECTIVENESS OF INHALED NITRIC OXIDE IN ARDS AND VIRAL PNEUMONIA WITH AND WITHOUT COVID-19
por: JR, RICHARD WALO, et al.
Publicado: (2022) -
Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
por: Law, Steven, et al.
Publicado: (2020) -
Transthyretin cardiac amyloidosis
por: Tomoaia, Raluca, et al.
Publicado: (2021) -
Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022)